| 0 |
GRIP STRENGTH |
13 |
0.0568 |
| 1 |
SWOLLEN JOINT COUNT |
12 |
0.0480 |
| 2 |
MEDICAL AID IN DYING |
1 |
0.0417 |
| 3 |
PARANEOPLASTIC RASH |
1 |
0.0357 |
| 4 |
FOLLICULAR LYMPHOMA STAGE IV |
1 |
0.0244 |
| 5 |
INFUSION SITE EXFOLIATION |
1 |
0.0192 |
| 6 |
BASOPHILIA |
1 |
0.0133 |
| 7 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
12 |
0.0127 |
| 8 |
ROSAI-DORFMAN SYNDROME |
1 |
0.0127 |
| 9 |
PORPHYRIA ACUTE |
17 |
0.0118 |
| 10 |
LUPUS VULGARIS |
13 |
0.0103 |
| 11 |
RETINITIS |
15 |
0.0087 |
| 12 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
16 |
0.0080 |
| 13 |
X-RAY ABNORMAL |
13 |
0.0073 |
| 14 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
4 |
0.0071 |
| 15 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
13 |
0.0063 |
| 16 |
DISLOCATION OF VERTEBRA |
13 |
0.0057 |
| 17 |
B-LYMPHOCYTE COUNT INCREASED |
1 |
0.0054 |
| 18 |
UPPER MOTOR NEURONE LESION |
1 |
0.0045 |
| 19 |
BONE EROSION |
16 |
0.0045 |
| 20 |
SWOLLEN JOINT COUNT INCREASED |
13 |
0.0041 |
| 21 |
FACET JOINT SYNDROME |
13 |
0.0040 |
| 22 |
PERIPHERAL VENOUS DISEASE |
16 |
0.0039 |
| 23 |
TOTAL LUNG CAPACITY INCREASED |
1 |
0.0037 |
| 24 |
INTERCEPTED PRODUCT STORAGE ERROR |
13 |
0.0036 |
| 25 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
13 |
0.0035 |
| 26 |
BLOOD VISCOSITY DECREASED |
1 |
0.0030 |
| 27 |
RHEUMATIC FEVER |
13 |
0.0029 |
| 28 |
ASTHMA EXERCISE INDUCED |
1 |
0.0029 |
| 29 |
HYPOCHOLESTEROLAEMIA |
1 |
0.0028 |
| 30 |
BREAST CANCER STAGE III |
18 |
0.0028 |
| 31 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
16 |
0.0025 |
| 32 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED |
1 |
0.0024 |
| 33 |
SINUS RHYTHM |
1 |
0.0023 |
| 34 |
DUODENAL ULCER PERFORATION |
17 |
0.0023 |
| 35 |
INTERCEPTED DRUG ADMINISTRATION ERROR |
1 |
0.0023 |
| 36 |
RHEUMATOID FACTOR POSITIVE |
13 |
0.0022 |
| 37 |
OESOPHAGEAL INFECTION |
1 |
0.0022 |
| 38 |
ALLERGY TO ARTHROPOD STING |
1 |
0.0022 |
| 39 |
INFUSION SITE HAEMATOMA |
1 |
0.0021 |
| 40 |
WALKING AID USER |
13 |
0.0020 |
| 41 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
14 |
0.0020 |
| 42 |
AORTIC VALVE CALCIFICATION |
1 |
0.0019 |
| 43 |
ABDOMINAL INJURY |
1 |
0.0019 |
| 44 |
C-REACTIVE PROTEIN ABNORMAL |
12 |
0.0019 |
| 45 |
EXOSTOSIS |
16 |
0.0018 |
| 46 |
INFUSION SITE REACTION |
5 |
0.0017 |
| 47 |
HELICOBACTER INFECTION |
17 |
0.0017 |
| 48 |
OPEN ANGLE GLAUCOMA |
1 |
0.0016 |
| 49 |
FOLLICULITIS |
17 |
0.0016 |
| 50 |
MONOCYTOSIS |
1 |
0.0016 |
| 51 |
MUSCLE INJURY |
13 |
0.0016 |
| 52 |
INFUSION SITE IRRITATION |
2 |
0.0016 |
| 53 |
MITRAL VALVE CALCIFICATION |
1 |
0.0016 |
| 54 |
HYPERCHOLESTEROLAEMIA |
15 |
0.0016 |
| 55 |
GRIP STRENGTH DECREASED |
13 |
0.0015 |
| 56 |
FOOT DEFORMITY |
16 |
0.0014 |
| 57 |
LUPUS-LIKE SYNDROME |
13 |
0.0014 |
| 58 |
LIP DRY |
13 |
0.0014 |
| 59 |
OVERLAP SYNDROME |
1 |
0.0014 |
| 60 |
CERVICAL RADICULOPATHY |
1 |
0.0014 |
| 61 |
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE |
1 |
0.0014 |
| 62 |
GRANULOMA ANNULARE |
1 |
0.0014 |
| 63 |
AUTOIMMUNE DISORDER |
13 |
0.0013 |
| 64 |
WOUND INFECTION |
14 |
0.0013 |
| 65 |
AORTIC DISORDER |
1 |
0.0013 |
| 66 |
PRODUCT CONFUSION |
1 |
0.0013 |
| 67 |
LIP ERYTHEMA |
1 |
0.0013 |
| 68 |
BURSITIS |
15 |
0.0012 |
| 69 |
LOWER RESPIRATORY TRACT CONGESTION |
2 |
0.0012 |
| 70 |
FOLLICULAR LYMPHOMA |
1 |
0.0011 |
| 71 |
PEMPHIGUS |
14 |
0.0011 |
| 72 |
JOINT RANGE OF MOTION DECREASED |
15 |
0.0011 |
| 73 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
1 |
0.0011 |
| 74 |
ANAEMIA OF CHRONIC DISEASE |
1 |
0.0011 |
| 75 |
C-REACTIVE PROTEIN |
1 |
0.0011 |
| 76 |
DRUG TOLERANCE DECREASED |
3 |
0.0011 |
| 77 |
HAND DEFORMITY |
14 |
0.0011 |
| 78 |
WEIGHT FLUCTUATION |
11 |
0.0011 |
| 79 |
SKIN TEXTURE ABNORMAL |
1 |
0.0010 |
| 80 |
BONE SWELLING |
1 |
0.0010 |
| 81 |
PERICARDITIS |
17 |
0.0010 |
| 82 |
INFUSION SITE DISCOMFORT |
1 |
0.0010 |
| 83 |
ONYCHOMADESIS |
4 |
0.0010 |
| 84 |
INFUSION SITE PRURITUS |
3 |
0.0009 |
| 85 |
SUSPECTED OFF LABEL USE |
4 |
0.0009 |
| 86 |
SUBCLAVIAN VEIN THROMBOSIS |
1 |
0.0009 |
| 87 |
PUSTULAR PSORIASIS |
3 |
0.0009 |
| 88 |
INTERCEPTED MEDICATION ERROR |
4 |
0.0009 |
| 89 |
OPTIC NERVE INJURY |
1 |
0.0009 |
| 90 |
HIP ARTHROPLASTY |
13 |
0.0008 |
| 91 |
LOWER LIMB FRACTURE |
16 |
0.0008 |
| 92 |
OBESITY |
13 |
0.0008 |
| 93 |
SCIATICA |
13 |
0.0008 |
| 94 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 95 |
HEPATIC CIRRHOSIS |
15 |
0.0008 |
| 96 |
PULMONARY FIBROSIS |
15 |
0.0008 |
| 97 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
13 |
0.0008 |
| 98 |
NEUROMYELITIS OPTICA SPECTRUM DISORDER |
1 |
0.0007 |
| 99 |
SYNOVITIS |
13 |
0.0007 |
| 100 |
EAR INFECTION |
18 |
0.0007 |
| 101 |
HAEMOGLOBIN INCREASED |
3 |
0.0007 |
| 102 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
11 |
0.0006 |
| 103 |
BLEPHAROSPASM |
4 |
0.0006 |
| 104 |
FREQUENT BOWEL MOVEMENTS |
17 |
0.0006 |
| 105 |
PNEUMONIA VIRAL |
2 |
0.0006 |
| 106 |
GLOSSODYNIA |
14 |
0.0006 |
| 107 |
IRRITABLE BOWEL SYNDROME |
13 |
0.0006 |
| 108 |
MEDICAL PROCEDURE |
1 |
0.0006 |
| 109 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 110 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
1 |
0.0006 |
| 111 |
MALIGNANT PLEURAL EFFUSION |
1 |
0.0006 |
| 112 |
MILIARIA |
1 |
0.0006 |
| 113 |
EAR PRURITUS |
2 |
0.0006 |
| 114 |
KNEE ARTHROPLASTY |
12 |
0.0006 |
| 115 |
BREAST CYST |
1 |
0.0006 |
| 116 |
HYPERACUSIS |
2 |
0.0005 |
| 117 |
FIBROMYALGIA |
13 |
0.0005 |
| 118 |
LIVER INJURY |
13 |
0.0005 |
| 119 |
SKIN WARM |
3 |
0.0005 |
| 120 |
LABORATORY TEST ABNORMAL |
15 |
0.0005 |
| 121 |
WOUND |
14 |
0.0005 |
| 122 |
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS |
1 |
0.0005 |
| 123 |
NO ADVERSE EVENT |
88 |
0.0005 |
| 124 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 125 |
TYPE 2 DIABETES MELLITUS |
16 |
0.0005 |
| 126 |
MIDDLE EAR EFFUSION |
1 |
0.0005 |
| 127 |
GASTROINTESTINAL ULCER |
1 |
0.0005 |
| 128 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
16 |
0.0005 |
| 129 |
WHITE BLOOD CELL COUNT INCREASED |
17 |
0.0004 |
| 130 |
CHRONIC GASTRITIS |
1 |
0.0004 |
| 131 |
OSTEOPOROSIS |
18 |
0.0004 |
| 132 |
ORAL PRURITUS |
1 |
0.0004 |
| 133 |
NIGHT SWEATS |
14 |
0.0004 |
| 134 |
PERFORMANCE STATUS DECREASED |
2 |
0.0004 |
| 135 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
2 |
0.0004 |
| 136 |
PSORIATIC ARTHROPATHY |
17 |
0.0004 |
| 137 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 138 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 139 |
PLATELET DISORDER |
1 |
0.0004 |
| 140 |
IMPAIRED HEALING |
13 |
0.0004 |
| 141 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
2 |
0.0004 |
| 142 |
LIPOMA |
1 |
0.0004 |
| 143 |
INJECTION SITE DISCOMFORT |
4 |
0.0004 |
| 144 |
JOINT DISLOCATION |
4 |
0.0004 |
| 145 |
DELIRIUM |
13 |
0.0004 |
| 146 |
RECTAL HAEMORRHAGE |
16 |
0.0004 |
| 147 |
BACK INJURY |
4 |
0.0004 |
| 148 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
4 |
0.0004 |
| 149 |
PANCREATITIS |
19 |
0.0004 |
| 150 |
TRICHORRHEXIS |
1 |
0.0004 |
| 151 |
INFUSION SITE ERYTHEMA |
3 |
0.0004 |
| 152 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 153 |
OSTEOARTHRITIS |
15 |
0.0004 |
| 154 |
GENERALISED ERYTHEMA |
2 |
0.0004 |
| 155 |
HYPERTONIC BLADDER |
1 |
0.0003 |
| 156 |
NECK INJURY |
1 |
0.0003 |
| 157 |
MYOSITIS |
3 |
0.0003 |
| 158 |
INJECTION SITE DISCOLOURATION |
4 |
0.0003 |
| 159 |
INFUSION SITE SWELLING |
2 |
0.0003 |
| 160 |
INFUSION RELATED REACTION |
21 |
0.0003 |
| 161 |
LIVER DISORDER |
14 |
0.0003 |
| 162 |
ROAD TRAFFIC ACCIDENT |
13 |
0.0003 |
| 163 |
LOWER RESPIRATORY TRACT INFECTION |
14 |
0.0003 |
| 164 |
INFLAMMATORY BOWEL DISEASE |
3 |
0.0003 |
| 165 |
COELIAC DISEASE |
3 |
0.0003 |
| 166 |
HYPOGAMMAGLOBULINAEMIA |
2 |
0.0003 |
| 167 |
FEELING HOT |
18 |
0.0003 |
| 168 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
14 |
0.0003 |
| 169 |
COLITIS ULCERATIVE |
13 |
0.0003 |
| 170 |
HYPOPNOEA |
1 |
0.0003 |
| 171 |
NEOPLASM PROGRESSION |
10 |
0.0003 |
| 172 |
LUNG DISORDER |
14 |
0.0003 |
| 173 |
INTENTIONAL PRODUCT USE ISSUE |
25 |
0.0003 |
| 174 |
STOMATITIS |
17 |
0.0003 |
| 175 |
ILL-DEFINED DISORDER |
17 |
0.0003 |
| 176 |
BLOOD CHOLESTEROL INCREASED |
13 |
0.0003 |
| 177 |
DISCOMFORT |
17 |
0.0003 |
| 178 |
INFLAMMATION |
14 |
0.0003 |
| 179 |
IMMUNODEFICIENCY |
4 |
0.0003 |
| 180 |
THYROID MASS |
1 |
0.0003 |
| 181 |
REHABILITATION THERAPY |
1 |
0.0003 |
| 182 |
OEDEMA |
14 |
0.0003 |
| 183 |
IDIOPATHIC PULMONARY FIBROSIS |
1 |
0.0003 |
| 184 |
ARTHROPATHY |
14 |
0.0003 |
| 185 |
BLISTER |
14 |
0.0002 |
| 186 |
TRIGEMINAL NEURALGIA |
1 |
0.0002 |
| 187 |
MUSCULOSKELETAL PAIN |
13 |
0.0002 |
| 188 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 189 |
WHEEZING |
14 |
0.0002 |
| 190 |
SWELLING |
22 |
0.0002 |
| 191 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 192 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 193 |
HEPATIC ENZYME INCREASED |
15 |
0.0002 |
| 194 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 195 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 196 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 197 |
MASS |
3 |
0.0002 |
| 198 |
MIGRAINE |
20 |
0.0002 |
| 199 |
CONTUSION |
20 |
0.0002 |
| 200 |
RASH VESICULAR |
1 |
0.0002 |
| 201 |
PRESCRIBED OVERDOSE |
4 |
0.0002 |
| 202 |
ARTHRITIS |
16 |
0.0002 |
| 203 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 204 |
PRESCRIBED UNDERDOSE |
4 |
0.0002 |
| 205 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 206 |
AMNESIA |
13 |
0.0002 |
| 207 |
PREGNANCY |
4 |
0.0002 |
| 208 |
INJURY |
14 |
0.0002 |
| 209 |
MOBILITY DECREASED |
14 |
0.0002 |
| 210 |
INJECTION SITE WARMTH |
4 |
0.0002 |
| 211 |
LYMPHOMA |
3 |
0.0002 |
| 212 |
VISUAL IMPAIRMENT |
24 |
0.0002 |
| 213 |
JOINT STIFFNESS |
5 |
0.0002 |
| 214 |
GASTROINTESTINAL DISORDER |
16 |
0.0002 |
| 215 |
PRODUCT STORAGE ERROR |
15 |
0.0002 |
| 216 |
SINUSITIS |
17 |
0.0002 |
| 217 |
INJECTION SITE RASH |
5 |
0.0002 |
| 218 |
DYSPEPSIA |
16 |
0.0002 |
| 219 |
DRY MOUTH |
13 |
0.0002 |
| 220 |
MATERNAL EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 221 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 222 |
INJECTION SITE INDURATION |
2 |
0.0002 |
| 223 |
HERPES SIMPLEX |
1 |
0.0002 |
| 224 |
BRONCHIECTASIS |
1 |
0.0001 |
| 225 |
MUSCULOSKELETAL STIFFNESS |
13 |
0.0001 |
| 226 |
SINUS CONGESTION |
2 |
0.0001 |
| 227 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 228 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 229 |
FORMICATION |
1 |
0.0001 |
| 230 |
SKIN REACTION |
2 |
0.0001 |
| 231 |
DUODENAL ULCER |
1 |
0.0001 |
| 232 |
RHEUMATOID ARTHRITIS |
16 |
0.0001 |
| 233 |
DIVERTICULUM |
1 |
0.0001 |
| 234 |
METASTASIS |
1 |
0.0001 |
| 235 |
ANOSMIA |
2 |
0.0001 |
| 236 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 237 |
RESPIRATORY DISORDER |
4 |
0.0001 |
| 238 |
ASTHMA |
15 |
0.0001 |
| 239 |
CONTRAINDICATED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 240 |
OEDEMA PERIPHERAL |
16 |
0.0001 |
| 241 |
HYPERTHERMIA |
1 |
0.0001 |
| 242 |
EPILEPSY |
4 |
0.0001 |
| 243 |
HAEMOLYSIS |
1 |
0.0001 |
| 244 |
INJECTION SITE ERYTHEMA |
16 |
0.0001 |
| 245 |
SENSORY DISTURBANCE |
2 |
0.0001 |
| 246 |
MUSCULAR WEAKNESS |
14 |
0.0001 |
| 247 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 248 |
HICCUPS |
1 |
0.0001 |
| 249 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 250 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
1 |
0.0001 |
| 251 |
GENERAL PHYSICAL HEALTH DETERIORATION |
14 |
0.0001 |
| 252 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 253 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 254 |
LIVE BIRTH |
1 |
0.0001 |
| 255 |
CELLULITIS |
6 |
0.0001 |
| 256 |
DISEASE PROGRESSION |
14 |
0.0001 |
| 257 |
INFECTION |
17 |
0.0001 |
| 258 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 259 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 260 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 261 |
INJECTION SITE REACTION |
8 |
0.0001 |
| 262 |
RASH |
50 |
0.0001 |
| 263 |
NAIL DISORDER |
1 |
0.0001 |
| 264 |
TUMOUR LYSIS SYNDROME |
1 |
0.0001 |
| 265 |
HYPOAESTHESIA |
17 |
0.0001 |
| 266 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 267 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 268 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 269 |
PERIPHERAL SWELLING |
17 |
0.0001 |
| 270 |
C-REACTIVE PROTEIN INCREASED |
4 |
0.0001 |
| 271 |
MEMORY IMPAIRMENT |
15 |
0.0001 |
| 272 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 273 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 274 |
NERVE COMPRESSION |
1 |
0.0001 |
| 275 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 276 |
FEELING COLD |
3 |
0.0001 |
| 277 |
JOINT SWELLING |
13 |
0.0001 |
| 278 |
ABDOMINAL DISCOMFORT |
18 |
0.0001 |
| 279 |
ERYTHEMA |
22 |
0.0001 |
| 280 |
ABDOMINAL PAIN UPPER |
22 |
0.0001 |
| 281 |
PHOTOPHOBIA |
2 |
0.0001 |
| 282 |
LEUKAEMIA |
1 |
0.0001 |
| 283 |
CONFUSIONAL STATE |
17 |
0.0001 |
| 284 |
ATELECTASIS |
1 |
0.0001 |
| 285 |
EAR PAIN |
2 |
0.0001 |
| 286 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 287 |
URTICARIA |
17 |
0.0001 |
| 288 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 289 |
HYPERTENSION |
21 |
0.0001 |
| 290 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 291 |
NASOPHARYNGITIS |
18 |
0.0001 |
| 292 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 293 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 294 |
HYPERSENSITIVITY |
18 |
0.0001 |
| 295 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 296 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 297 |
PARAESTHESIA |
15 |
0.0001 |
| 298 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 299 |
SCRATCH |
1 |
0.0001 |
| 300 |
DECREASED APPETITE |
22 |
0.0001 |
| 301 |
CHILLS |
11 |
0.0001 |
| 302 |
OFF LABEL USE |
82 |
0.0001 |
| 303 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 304 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 305 |
TREATMENT NONCOMPLIANCE |
5 |
0.0001 |
| 306 |
ABDOMINAL PAIN |
21 |
0.0001 |
| 307 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
4 |
0.0001 |
| 308 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 309 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 310 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 311 |
VASCULITIS |
1 |
0.0001 |
| 312 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 313 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
3 |
0.0001 |
| 314 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 315 |
PNEUMONIA |
27 |
0.0001 |
| 316 |
MUSCLE SPASMS |
15 |
0.0001 |
| 317 |
CYTOPENIA |
1 |
0.0001 |
| 318 |
CARDIOMEGALY |
1 |
0.0001 |
| 319 |
CHEST PAIN |
15 |
0.0001 |
| 320 |
CYST |
1 |
0.0001 |
| 321 |
AGEUSIA |
2 |
0.0001 |
| 322 |
HYPOPHAGIA |
2 |
0.0001 |
| 323 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 324 |
HAEMATOMA |
2 |
0.0001 |
| 325 |
DIPLOPIA |
2 |
0.0001 |
| 326 |
ALOPECIA |
15 |
0.0001 |
| 327 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 328 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 329 |
MENSTRUATION IRREGULAR |
2 |
0.0001 |
| 330 |
NEUTROPHIL COUNT DECREASED |
3 |
0.0001 |
| 331 |
TACHYPNOEA |
1 |
0.0001 |
| 332 |
GAIT DISTURBANCE |
14 |
0.0001 |
| 333 |
DRUG INTOLERANCE |
7 |
0.0001 |
| 334 |
NECK PAIN |
4 |
0.0001 |
| 335 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 336 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 337 |
SLEEP DISORDER |
5 |
0.0001 |
| 338 |
PAIN IN JAW |
2 |
0.0001 |
| 339 |
DEPRESSION |
16 |
0.0001 |
| 340 |
HYPOKINESIA |
1 |
0.0001 |
| 341 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 342 |
THROAT IRRITATION |
3 |
0.0001 |
| 343 |
ANXIETY |
19 |
0.0001 |
| 344 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 345 |
HYPOKALAEMIA |
3 |
0.0001 |
| 346 |
WEIGHT DECREASED |
18 |
0.0001 |
| 347 |
INSOMNIA |
17 |
0.0001 |
| 348 |
BRAIN FOG |
1 |
0.0001 |
| 349 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 350 |
WEIGHT INCREASED |
14 |
0.0001 |
| 351 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 352 |
MANIA |
1 |
0.0001 |
| 353 |
PYREXIA |
21 |
0.0001 |
| 354 |
SKIN DISORDER |
2 |
0.0001 |
| 355 |
PRURITUS |
23 |
0.0001 |
| 356 |
GAIT INABILITY |
2 |
0.0001 |
| 357 |
MALIGNANT NEOPLASM PROGRESSION |
6 |
0.0001 |
| 358 |
SCAR |
1 |
0.0001 |
| 359 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 360 |
EOSINOPHILIA |
1 |
0.0001 |
| 361 |
HEART RATE DECREASED |
2 |
0.0001 |
| 362 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 363 |
DRUG ERUPTION |
1 |
0.0001 |
| 364 |
PLATELET COUNT DECREASED |
6 |
0.0001 |
| 365 |
GOUT |
1 |
0.0001 |
| 366 |
ADVERSE DRUG REACTION |
5 |
0.0001 |
| 367 |
TOOTHACHE |
1 |
0.0001 |
| 368 |
MALAISE |
24 |
0.0001 |
| 369 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 370 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 371 |
ADVERSE EVENT |
5 |
0.0001 |
| 372 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 373 |
DIZZINESS |
27 |
0.0001 |
| 374 |
INJECTION SITE MASS |
2 |
0.0001 |
| 375 |
MEDICATION ERROR |
3 |
0.0001 |
| 376 |
EYE SWELLING |
2 |
0.0001 |
| 377 |
PAIN |
33 |
0.0001 |
| 378 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 379 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 380 |
NEUROPATHY PERIPHERAL |
5 |
0.0001 |
| 381 |
INCREASED APPETITE |
1 |
0.0001 |
| 382 |
HERPES ZOSTER |
3 |
0.0001 |
| 383 |
INJECTION SITE PAIN |
16 |
0.0001 |
| 384 |
NEUTROPENIA |
7 |
0.0001 |
| 385 |
DISABILITY |
1 |
0.0001 |
| 386 |
SINUS DISORDER |
1 |
0.0001 |
| 387 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 388 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 389 |
CONDITION AGGRAVATED |
15 |
0.0000 |
| 390 |
TASTE DISORDER |
1 |
0.0000 |
| 391 |
FLUSHING |
5 |
0.0000 |
| 392 |
TREATMENT FAILURE |
4 |
0.0000 |
| 393 |
MOUTH ULCERATION |
1 |
0.0000 |
| 394 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 395 |
VOMITING |
22 |
0.0000 |
| 396 |
SKIN CANCER |
1 |
0.0000 |
| 397 |
FATIGUE |
36 |
0.0000 |
| 398 |
DYSPNOEA |
26 |
0.0000 |
| 399 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 400 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 401 |
ANGIOEDEMA |
2 |
0.0000 |
| 402 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 403 |
HEADACHE |
28 |
0.0000 |
| 404 |
RASH PAPULAR |
1 |
0.0000 |
| 405 |
NAUSEA |
35 |
0.0000 |
| 406 |
ARTHRALGIA |
18 |
0.0000 |
| 407 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 408 |
ASTHENIA |
16 |
0.0000 |
| 409 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 410 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 411 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 412 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 413 |
PRESYNCOPE |
1 |
0.0000 |
| 414 |
NEURALGIA |
1 |
0.0000 |
| 415 |
PRODUCT USE IN UNAPPROVED INDICATION |
10 |
0.0000 |
| 416 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 417 |
HEPATITIS |
1 |
0.0000 |
| 418 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 419 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 420 |
HYPERHIDROSIS |
5 |
0.0000 |
| 421 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 422 |
DIARRHOEA |
25 |
0.0000 |
| 423 |
RASH GENERALISED |
1 |
0.0000 |
| 424 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 425 |
NERVOUSNESS |
2 |
0.0000 |
| 426 |
PAIN OF SKIN |
1 |
0.0000 |
| 427 |
RASH PRURITIC |
2 |
0.0000 |
| 428 |
PALLOR |
1 |
0.0000 |
| 429 |
PNEUMONITIS |
1 |
0.0000 |
| 430 |
VISION BLURRED |
5 |
0.0000 |
| 431 |
HAEMOPTYSIS |
1 |
0.0000 |
| 432 |
PANCYTOPENIA |
2 |
0.0000 |
| 433 |
EYE PAIN |
2 |
0.0000 |
| 434 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 435 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 436 |
BONE PAIN |
2 |
0.0000 |
| 437 |
CATARACT |
2 |
0.0000 |
| 438 |
VERTIGO |
2 |
0.0000 |
| 439 |
HEAD INJURY |
1 |
0.0000 |
| 440 |
CYSTITIS |
1 |
0.0000 |
| 441 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 442 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 443 |
HIP FRACTURE |
1 |
0.0000 |
| 444 |
SWELLING FACE |
2 |
0.0000 |
| 445 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 446 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 447 |
LIP SWELLING |
1 |
0.0000 |
| 448 |
URINARY RETENTION |
1 |
0.0000 |
| 449 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 450 |
HYPOTENSION |
6 |
0.0000 |
| 451 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 452 |
NIGHTMARE |
1 |
0.0000 |
| 453 |
COUGH |
8 |
0.0000 |
| 454 |
BURNING SENSATION |
2 |
0.0000 |
| 455 |
HYPERKALAEMIA |
1 |
0.0000 |
| 456 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 457 |
BRONCHITIS |
2 |
0.0000 |
| 458 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 459 |
EPISTAXIS |
2 |
0.0000 |
| 460 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 461 |
HOT FLUSH |
2 |
0.0000 |
| 462 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 463 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 464 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 465 |
HOSPITALISATION |
4 |
0.0000 |
| 466 |
INJECTION SITE HAEMORRHAGE |
2 |
0.0000 |
| 467 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 468 |
POLLAKIURIA |
1 |
0.0000 |
| 469 |
PAIN IN EXTREMITY |
7 |
0.0000 |
| 470 |
MYALGIA |
4 |
0.0000 |
| 471 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 472 |
TACHYCARDIA |
2 |
0.0000 |
| 473 |
DEATH |
19 |
0.0000 |
| 474 |
SKIN IRRITATION |
1 |
0.0000 |
| 475 |
RENAL DISORDER |
1 |
0.0000 |
| 476 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 477 |
CARDIAC DISORDER |
2 |
0.0000 |
| 478 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 479 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 480 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 481 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 482 |
LEUKOPENIA |
1 |
0.0000 |
| 483 |
SYNCOPE |
2 |
0.0000 |
| 484 |
FLUID RETENTION |
1 |
0.0000 |
| 485 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 486 |
ILLNESS |
2 |
0.0000 |
| 487 |
INFLUENZA |
2 |
0.0000 |
| 488 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 489 |
FLATULENCE |
1 |
0.0000 |
| 490 |
EYE IRRITATION |
1 |
0.0000 |
| 491 |
DYSPHONIA |
1 |
0.0000 |
| 492 |
PALPITATIONS |
2 |
0.0000 |
| 493 |
NASAL CONGESTION |
1 |
0.0000 |
| 494 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 495 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 496 |
RENAL FAILURE |
2 |
0.0000 |
| 497 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 498 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 499 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 500 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 501 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 502 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 503 |
CONSTIPATION |
3 |
0.0000 |
| 504 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 505 |
UNDERDOSE |
1 |
0.0000 |
| 506 |
HALLUCINATION |
1 |
0.0000 |
| 507 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 508 |
BACK PAIN |
3 |
0.0000 |
| 509 |
TREMOR |
2 |
0.0000 |
| 510 |
FALL |
4 |
0.0000 |
| 511 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 512 |
BALANCE DISORDER |
1 |
0.0000 |
| 513 |
COVID-19 |
2 |
0.0000 |
| 514 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 515 |
BREAST CANCER |
1 |
0.0000 |
| 516 |
DRUG INEFFECTIVE |
14 |
0.0000 |
| 517 |
ANAEMIA |
2 |
0.0000 |
| 518 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 519 |
SOMNOLENCE |
2 |
0.0000 |
| 520 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 521 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 522 |
SEPSIS |
1 |
0.0000 |
| 523 |
FEELING ABNORMAL |
2 |
0.0000 |
| 524 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 525 |
DRUG INTERACTION |
1 |
0.0000 |
| 526 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 527 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 528 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 529 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |